Quantification of cardiovascular biomarkers in patient plasma by targeted mass spectrometry and stable isotope dilution. - Wikidata - wikimedia - TriplyDB

Quantification of cardiovascular biomarkers in patient plasma by targeted mass spectrometry and stable isotope dilution.

Quantification of cardiovascular biomarkers in patient plasma by targeted mass spectrometry and stable isotope dilution.

http://www.wikidata.org/entity/Q37379631

about

Metabolomics reveals amino acids contribute to variation in response to simvastatin treatment Utility of mass spectrometry for the diagnosis of the unstable coronary plaque Emerging protein array technologies for proteomics Applications of targeted proteomics in systems biology and translational medicine Targeted proteomics for biomarker discovery and validation of hepatocellular carcinoma in hepatitis C infected patients Proteolysis controls endogenous substance P levels Design, implementation and multisite evaluation of a system suitability protocol for the quantitative assessment of instrument performance in liquid chromatography-multiple reaction monitoring-MS (LC-MRM-MS)Elective affinities--bioinformatic analysis of proteomic mass spectrometry data.Discovery of colorectal cancer biomarker candidates by membrane proteomic analysis and subsequent verification using selected reaction monitoring (SRM) and tissue microarray (TMA) analysis Sampling the N-terminal proteome of human blood.Stable-isotope dilution LC–MS for quantitative biomarker analysis.Automated detection of inaccurate and imprecise transitions in peptide quantification by multiple reaction monitoring mass spectrometry.Plasma protein profiling reveals protein clusters related to BMI and insulin levels in middle-aged overweight subjects Proteogenomic convergence for understanding cancer pathways and networks.Cardiovascular proteomics: translational studies to develop novel biomarkers in heart failure and left ventricular remodeling.mProphet: automated data processing and statistical validation for large-scale SRM experiments.The Human Proteome Organization Chromosome 6 Consortium: integrating chromosome-centric and biology/disease driven strategies SRMBuilder: a user-friendly tool for selected reaction monitoring data analysis.Quantitative proteomics in cardiovascular research: global and targeted strategies Multi-peptide nLC-PC-IDMS-SRM-based assay for the quantification of biomarkers in the chicken ovarian cancer model An assessment of current bioinformatic solutions for analyzing LC-MS data acquired by selected reaction monitoring technology.Peptidomics approach to elucidate the proteolytic regulation of bioactive peptides.Antibody-independent targeted quantification of TMPRSS2-ERG fusion protein products in prostate cancer.Synthetic peptide arrays for pathway-level protein monitoring by liquid chromatography-tandem mass spectrometry.Toward sensitive and accurate analysis of antibody biotherapeutics by liquid chromatography coupled with mass spectrometry.Effect of collision energy optimization on the measurement of peptides by selected reaction monitoring (SRM) mass spectrometry.Stable isotope imaging of biological samples with high resolution secondary ion mass spectrometry and complementary techniques.Statistical characterization of multiple-reaction monitoring mass spectrometry (MRM-MS) assays for quantitative proteomics.Improved detection specificity for plasma proteins by targeting cysteine-containing peptides with photo-SRM.The sweet and sour of serological glycoprotein tumor biomarker quantification.Index-ion triggered MS2 ion quantification: a novel proteomics approach for reproducible detection and quantification of targeted proteins in complex mixtures.Targeted quantitation of proteins by mass spectrometry.Evaluation of large scale quantitative proteomic assay development using peptide affinity-based mass spectrometry.Proteome and transcriptome profiles of a Her2/Neu-driven mouse model of breast cancer.Methods for peptide and protein quantitation by liquid chromatography-multiple reaction monitoring mass spectrometry.Quantification of activated NF-kappaB/RelA complexes using ssDNA aptamer affinity-stable isotope dilution-selected reaction monitoring-mass spectrometry Automated sample preparation platform for mass spectrometry-based plasma proteomics and biomarker discovery Rapid verification of candidate serological biomarkers using gel-based, label-free multiple reaction monitoring.A targeted proteomics-based pipeline for verification of biomarkers in plasma 18O-labeled proteome reference as global internal standards for targeted quantification by selected reaction monitoring-mass spectrometry.

P2860

Q21561017-9C500982-3397-41E4-92E9-A62592F9AC46 Q26780282-59FA9026-CC27-4BAD-9AB0-D0D2956ACA34 Q26824107-DBC44925-10CF-4F70-A79C-B43BE0E98036 Q26852271-1614B992-6059-4362-8A2F-9CE309109A0C Q28085015-AE663F95-4E21-4B58-8178-EB52569C07D2 Q28534739-AB89DA5E-ECED-4268-84F3-A74E14DBF2C5 Q28681060-DD352641-D620-4234-9E78-D79EC4B1F7DD Q33515901-E83B78E5-857D-4324-B395-1DE66CDADC8C Q33718710-B7963C34-076B-466D-9F29-826B186C340A Q33740667-E283C22E-E634-45E7-AEB4-5589237AEF6A Q33747062-6EC1A0B5-21C8-4172-9D5B-783960D95019 Q33775524-A5EBEC5E-6119-42D7-AEB7-37DEDE0B2BF8 Q33784462-E446F53F-1550-43AF-8785-EF72637FBFF0 Q33792433-85BE61C4-3B10-4FEE-8FCC-96671052001B Q33797033-9680BE41-FED7-478E-A593-183A0E323C0A Q33851184-D67120C4-7EDC-47F4-8BCD-CB839CE3531A Q33897503-5BC4CAAC-0F42-4A5E-8B5E-C5F551DEA392 Q34092297-A00F8DFB-3F57-41AD-8B85-86459B244AA6 Q34156082-320C128D-CE67-4FF1-9B30-3F3CAAEC56A0 Q34180244-61E89AAB-BFBF-4284-9F42-5BA061CFCC2E Q34265969-2AC0C8FA-CD4A-4C9A-BAC8-715C3C165974 Q34268925-6B211F17-3A73-4146-9182-6D49D5F058B1 Q34283031-C7334F24-84F8-49C1-ACD5-62E69A2F2E81 Q34320740-24B7FF96-D0AB-44B5-BA4F-F247BF6CA22B Q34359998-1FAA9E50-F5FA-4FEF-9E08-4028957AF617 Q34421676-95E2F22E-C89D-4DFD-AC78-5266CB2B598C Q34463873-ABBD846D-E79A-4BD5-8A1A-BF08E86C2D93 Q34487045-2F6CF5BA-B5A1-4B79-A06B-ECBB027E4B54 Q34550436-D92023A4-A4FD-4654-96CB-1E746AB4AA5E Q34580285-6B5E38A4-15E6-45F9-AF52-36B8912306C7 Q34616855-3BD8102D-56BA-472E-AF52-19A8834B7D87 Q34630866-191E77AA-7F5E-42B9-BCDC-89800C3E5BD1 Q34751690-C5869073-A7DC-4994-923E-BA660E8C7E0A Q34754750-5E2C388D-EB02-4EF9-A2D9-21B98B3C6F9B Q35026899-6BD2EE1F-B4B0-49B2-85B3-E570AC483CE8 Q35026929-D5FD6C38-1D8F-432A-BABC-82577A55DC64 Q35169652-16C87E99-6141-4C8A-9A5A-36D51EC7700E Q35194600-052AD2B2-2782-4D04-99CC-3A0737078127 Q35596338-7ACE5524-E0DD-4638-ACBE-7842012EA99A Q35610629-378CA86A-9809-440E-A122-BB386A6BFCCE

P2860

Quantification of cardiovascular biomarkers in patient plasma by targeted mass spectrometry and stable isotope dilution.

http://www.wikidata.org/entity/Q37379631

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 13 July 2009

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Quantification of cardiovascul ...... y and stable isotope dilution.

@en

Quantification of cardiovascul ...... y and stable isotope dilution.

@nl

type

label

Quantification of cardiovascul ...... y and stable isotope dilution.

@en

Quantification of cardiovascul ...... y and stable isotope dilution.

@nl

prefLabel

Quantification of cardiovascul ...... y and stable isotope dilution.

@en

Quantification of cardiovascul ...... y and stable isotope dilution.

@nl

P1433

Q37379631-2C310B2F-02AE-4E82-9304-9546AAAA12A8

P1476

Q37379631-5900AA09-CF5B-48C2-B8AE-6B38E365AFD9

P2093

Q37379631-331DF917-40BD-4015-B45C-C34023729F55

Q37379631-3CFC906A-4984-45A4-A637-358F421D06E5

Q37379631-438D20E0-6751-4D88-879A-C139B3208F8A

Q37379631-4ADB3A58-8B40-4D19-854F-5FED49347262

Q37379631-50357140-F460-4DDB-961B-EB798D72A99D

Q37379631-787B1AEC-C503-4679-BCAD-F2D9BA4FA040

Q37379631-DDE679C2-04DC-48C5-8A33-9F4B4EC9D011

Q37379631-EAD330CD-B596-413F-A710-3948D361989C

P2860

Q37379631-06CE440A-B1DB-4397-9EC4-447C7DB74C4C

Q37379631-15C0B419-252E-4FC5-B3CC-56E28C0BD377

Q37379631-1956BDFA-BE14-478E-9BDC-C59DAE9B0E8C

Q37379631-3938F20F-E6B7-446A-B2C3-131B37665E29

Q37379631-5A4BBC96-2748-4A64-BC7D-7B7AF9E58BFC

Q37379631-69180274-96E1-44F2-B0AD-8DB194FF2162

Q37379631-743E2383-57CD-44C5-A902-189EE0F467B3

Q37379631-7C0C887F-ADEA-4B51-97CD-59EA921A9C4F

Q37379631-8A4640DB-87DB-46F8-8FFC-F452F1BFF593

Q37379631-B157C697-DC3C-4FE2-80DF-DD058F9BA100

P304

Q37379631-C1925E0A-3C60-4491-884D-F496A55E02F3

P31

Q37379631-1C5C0B4A-3C4B-4A6A-A017-FD8A6D5FB7FA

P356

Q37379631-A042F534-9FAE-4999-9E86-5307C5E617CB

P433

Q37379631-8D03C703-22C9-48E9-BC33-70782F26B299

P478

Q37379631-3AE7D48F-39E7-4A0D-B3EF-EE064BA01004

P50

Q37379631-875A152E-021A-432D-93F4-0E264FAC66E0

P577

Q37379631-C29577E6-5A15-481F-B23F-BD7B1C041ECE

P698

Q37379631-E087F619-AD35-456E-A524-CF3EAB4E2FD0

P921

Q37379631-48060C81-5717-4BB0-B113-AD0701EC29CE

Q37379631-95B1ADF6-0C37-4FCF-808E-0FDACBD804AD

Q37379631-A1AAFDE3-A97A-4AF9-B5C3-3DDB62FE2D4C

Q37379631-BF62B466-3759-4837-B623-54D2B4075D1F

P932

Q37379631-1F955A17-E44D-4064-AA5F-E075B20F3DE6

P356

MCP.M900140-MCP200

P1433

Molecular & Cellular Proteomics

P1476

Quantification of cardiovascul ...... ry and stable isotope dilution

@en

P2093

Eric Kuhn

http://www.w3.org/2001/XMLSchema#string

Hasmik Keshishian

http://www.w3.org/2001/XMLSchema#string

Marc S Sabatine

http://www.w3.org/2001/XMLSchema#string

Michael Burgess

http://www.w3.org/2001/XMLSchema#string

Robert E Gerszten

http://www.w3.org/2001/XMLSchema#string

Steven A Carr

http://www.w3.org/2001/XMLSchema#string

Terri Addona

http://www.w3.org/2001/XMLSchema#string

Xu Shi

http://www.w3.org/2001/XMLSchema#string

P2860

Metabolite profiling of blood from individuals undergoing planned myocardial infarction reveals early markers of myocardial injury

Pathological effects of alcohol septal ablation for hypertrophic obstructive cardiomyopathy

Developing multiplexed assays for troponin I and interleukin-33 in plasma by peptide immunoaffinity enrichment and targeted mass spectrometry

Quantification of C-reactive protein in the serum of patients with rheumatoid arthritis using multiple reaction monitoring mass spectrometry and 13C-labeled peptide standards.

Quantification of thyroglobulin, a low-abundance serum protein, by immunoaffinity peptide enrichment and tandem mass spectrometry

Concurrent evaluation of novel cardiac biomarkers in acute coronary syndrome: myeloperoxidase and soluble CD40 ligand and the risk of recurrent ischaemic events in TACTICS-TIMI 18.

New treatment methods for patients with hypertrophic obstructive cardiomyopathy.

The interface between biomarker discovery and clinical validation: The tar pit of the protein biomarker pipeline.

A new biometrical procedure for testing the equality of measurements from two different analytical methods. Application of linear regression procedures for method comparison studies in clinical chemistry, Part I.

Cardiac troponin assays: a view from the clinical chemistry laboratory.

P304

2339-2349

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1074/MCP.M900140-MCP200

http://www.w3.org/2001/XMLSchema#string

P433

10

http://www.w3.org/2001/XMLSchema#string

P478

8

http://www.w3.org/2001/XMLSchema#string

P50

P577

2009-07-13T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

19596694

http://www.w3.org/2001/XMLSchema#string

P921

Aparato circulatorio

P932

2758760

http://www.w3.org/2001/XMLSchema#string